SlideShare a Scribd company logo
1 of 22
Download to read offline
Sangwei Lu, Ph.D.
School of Public Health
University of California
Berkeley, California
U. S. A.
Email: sangwei@berkeley.edu
Phone: (510) 643-4986
Website: http://sph.berkeley.edu/sangwei-lu
Novel, Peanut Butter – Based
Formulation of Amoxicillin
- Toward a child–friendly formulation of amoxicillin
that is stable, ready to use and nutritious
The Need for a Child –Friendly
Formulation of Amoxicillin
• Young children cannot swallow pills.
• Needs clean water to reconstitute
• Needs refrigeration once reconstituted
• Heavy to transport once reconstituted
Peanut butter – based formulation of amoxicillin (NutMox)
• Child-friendly and nutritious
• Ready to use and light weight; no refrigeration
necessary
• Can be combined with RUTF therapy based on
updated WHO guidelines of management of
severe acute malnutrition in children
Sangwei Lu, PhD, sangwei@berkeley.edu Novel, Peanut Butter – Based Formulation of Amoxicillin
Design of Peanut Butter–Based
Formulation of Amoxicillin
packaged and distributed as a single course of antibiotic treatment
Advantages
• Easy to handle
• Easy to track
• Helps ensure completion of full course of treatment and
prevent emergence of drug resistance
Sangwei Lu, PhD, sangwei@berkeley.edu Novel, Peanut Butter – Based Formulation of Amoxicillin
Project Plan
• Formulate a suitable peanut butter base for amoxicillin
• Test the long term stability of amoxicillin in the peanut
butter base under various storage temperatures
• Determine the pharmacokinetics of NutMox in an
animal model
• Test the efficacy of NutMox in a mouse pneumonia
model.
Preliminary Results
• Amoxicillin is very stable in peanut butter base
with various ratios of peanut butter, sugar,
vegetable oil and dry milk.
• Peanut butter base does not prevent amoxicillin
from being released into mouse bloodstream.
Sangwei Lu, PhD, sangwei@berkeley.edu Novel, Peanut Butter – Based Formulation of Amoxicillin
• Prepare in vitro data for FDA Investigational New
Drug (IND) filing.
• Clinical trial – bioequivalence study
• FDA New Drug Application (NDA) filing
• Partner with pharmaceutical companies, NGOs and
non-profit organizations.
Future Directions - Path to Clinical Use
Community Input
• Requirements and feasibility of NutMox in the field
• Regulatory requirements of the countries NutMox is
most likely to be used
• Route of distribution
• Connection with clinicians and organizations
Sangwei Lu, PhD, sangwei@berkeley.edu Novel, Peanut Butter – Based Formulation of Amoxicillin
UCL SCHOOL OF PHARMACY
BRUNSWICK SQUARE
Child Friendly Formulations of Amoxicillin:
RAMOX
Dr Catherine Tuleu, Reader of Pharmaceutics
Dr Sara Hanning, Research Associate
UCL School of Pharmacy, London, UK
UCL SCHOOL OF PHARMACY
BRUNSWICK SQUARE
Paediatric Pharmacy R & D
 Manipulation & Compounding
– Reformulation/repurposing of API for (ultra) rare diseases
– Palliative care
 Excipients tolerability and safety
– STEP Database (www.eupfi.org)
 Appropriateness of dosage forms (including acceptability)
– RAMOX
– Multiparticulates
– Flexible solid oral dosage forms
 Palatability of formulations
– In vivo (human panels)/in vitro (BATA model) tools
– HME for TM of FDC TB drugs
– Cocrystals for TM for neglected infectious diseases
 Drug delivery/administration devices
– Nipple shield 7
UCL SCHOOL OF PHARMACY
BRUNSWICK SQUARE
Child-friendly formulations of amoxicillin: Exploring the
rectal route
Jannin V, Lemagnen G, Gueroult P, Larrouture D, Tuleu C (2014). Advanced Drug Delivery Reviews 73(0):34-49.
8
UCL SCHOOL OF PHARMACY
BRUNSWICK SQUARE
Advantages
 Low manufacture cost
 Ease of administration (no
need for trained carers)
 Avoidance of
taste/swallowability
concerns
Challenges
 Ability to withstand high-
temperature environments
 Offer immediate and
predictable drug release in
vivo
The rectal route
UCL SCHOOL OF PHARMACY
BRUNSWICK SQUARE
 Screen potential excipients for irritability
 Development, optimisation and characterisation of formulations
 Physical and chemical data essential to ensure quality, stability
and an immediate drug release profile
 PPI
…to bring forward to Phase II
 Clinical efficacy
 Paediatric Investigation Plan (PIP)/Paediatric Use Marketing
Authorisation (PUMA)
 Educational material to promote and support rectal
administration
Phase I: Pharmaceutical development
10
Phase II: Translation of research
The Challenge
Beta-lactam bonds in amoxicillin are hydrolyzed (broken down) by water causing
reconstituted amoxicillin the degenerate within 2 weeks and faster if no cold chain
(refrigeration) is present. DOM (dissolved organic matter) also contribute to 48-74% of
amoxicillin loss if reconstituted with natural waters. Direct sunlight further contributes to
the photochemical degradation especially in the presence of DOM.
Problems encountered in low resource settings
No refrigeration
“Dirty” water – leading to contamination of the reconstituted antibiotic – also contains
DOM
High temperatures in some parts of the developing world – Africa, South East Asia etc
Hypothesis
If water hydrolyzes the Beta-lactam bonds it is acceptable to say oil will not. An oil based
suspension will lead to a suspension that will stay chemically stable with therapeutic
efficacy intact for periods of up to 2 years, without cold chain and at very high
temperatures as experienced in many parts of the world.
Water:
is a polar molecule with a dipole moment
can act as an acid or a base (Bronsted Lowry)
has strong hydrogen bonds
Amoxicillin:
is predominantly a polar molecule (polar dissolves in polar)
Oil :
is a non-polar molecule
Other issues with water in LMICs:
Water is mostly contaminated and contains dissolved organic matter
DOMs accelerate hydrolysis
PH also plays a role – should be between 3 and 6 (approximate)
Temperature – in water should be at between 4 and 8 Celsius
At temperatures above 37 Celsius – hydrolysis is accelerated
Direct sunight – accelerates photolysis
Benefits of an oil based suspension:
• Such a suspension will not require refrigeration,
• will eliminate contamination risks
• stay stable at very high temperatures of 40 to 50 degrees Celsius.
• Added benefit of using oil is that oil provides plus minus 9 calories per gram, giving more energy to the child to fight the
infection.
• Individualized dosing units clearly marked for populations of LMICs
• Mix amoxicillin with various non-volatile oils and triglycerides.
• Add silicon dioxide as adsorbent and anti-caking agent
• Any flavoring and colorant can be added
Testing conditions as per generic protocol (WHO) and USP
• Long term testing conditions for South Africa (Zone II) = 25°C/60%RH
• Long Term Testing conditions for Zone IVB countries (hot and very humid
conditions) + intermediate conditions for Zone II = 30°C/75%RH
• Accelerated stability testing conditions = 40°C/75%RH
• *%RH = Relative Humidity
.
Stability Testing Phase I
Method and Metrics Desired Outcome
Physical analysis: Description and
Appearance; odour, colour, palatability,
uniformity, dissolution
Original physical properties are retained
Chemical analysis: Ph, density, viscosity Original chemical properties are retained
Re-suspendability Suspendability is retained
Uniformity of dosing units: weight
variation
Chemical integrity and labelled potency
are retained
Chemical assay: Assay Amox Suitability of method must be proven
Sterility No contamination
Microbiological: resistance to
microbiological growth and no
contamination
Amoxicillin retains its antimicrobial
effectiveness
Photostability: direct sunlight Determine suitability of amber/clear
ampoules
Research Phase II
Method and Metrics Desired Outcome
Therapeutic efficacy Remains unchanged
Bioavailability Remains within specified limits
Safety Safety remains within current limits
Toxicological No increase in adverse events and side
effects
Our product will be safe with no added allergens and we expect no increase in
side effects and adverse events.
Conclusion
Amoxicillin is an existing API - all testing should remain within current limitations.
However, if we could include a comparative study our data will be more unbiased
and we will be able to accelerate phase I and II drastically – especially if we could
test both child formulations 125mg/5ml and 250mg/5ml.
THANK YOU
A Thixotropic System for Oral
Delivery of Amoxicillin in Treating
Pneumonia in Children
Chenjie Xu
Assistant Professor
School of Chemical and Biomedical Engineering
Nanyang Technological University
Singapore
16
Challenges of Amoxicillin Delivery to Children
(0-5 yrs) at High Burden Countries
http://www.envita.com/
Amoxicillin
17
Criteria of an Ideal Formulation
1. Taste-masked
2. Easy to swallow
3. No need of clean water
4. Improved shelf life without the need of refrigeration
5. Low cost
http://gcgh.grandchallenges.org/Explorations/Topics/Pages/ChildhoodPneumoniaTreatment_Round14.aspx
18
Birth of Idea
Images are adapted from Waker silicone electronic business. Co. Ltd
19
Components of a Thixotropic System
1. A coating that blocks the unappealing taste and odor of
Amoxicillin;
2. A water-containing matrix that disperses, stabilizes,
and delivers the drug.
20
Spray-drying Synthesis of Amoxicillin
Micro/nano-particles
• Poly(meth)acrylates polymer (trade name:
EUDRAGIT® E) seals taste and masks odor.
• Soluble in solution (pH <5.0)
Amoxicillin
• Poorly water-soluble (0.004g/ml)
• Insoluble in organic solvents like
chloroform.
• Its sodium salt is soluble in water
(0.05g/ml)
An acidic solution of
Amoxicillin sodium
and Eugragit E
Harsha S. Drug design, development and therapy 2013, 7, 1027
Khachane,P et al, Journal of biomedical nanotechnology 2001, 7, 590
21
Encapsulation of Amoxicillin Particles in Sodium
Carboxymethyl Cellulose Hydrogel
High and medium-viscosity types of sodium carboxymethyl cellulose
(SCC) solution exhibit thixotropic behavior and acts like liquid under
the pressure.
http://www.dow.com/; Lee, C.H., Moturi, V. & Lee, Y. Journal of Controlled Release 2009, 136, 88
+
SCCAmoxicillin Particles
Mechanical Stirring
22

More Related Content

Similar to Pediatric Antibiotic Innovations

Mkt 1043 stability and efficiency testing-SPPT23
Mkt 1043 stability and efficiency testing-SPPT23Mkt 1043 stability and efficiency testing-SPPT23
Mkt 1043 stability and efficiency testing-SPPT23DrMariani
 
Bioavailability and Bioequivalence study
Bioavailability and Bioequivalence studyBioavailability and Bioequivalence study
Bioavailability and Bioequivalence studyMcpl Moshi
 
Bioavailability and bioequivalence study
Bioavailability and bioequivalence studyBioavailability and bioequivalence study
Bioavailability and bioequivalence studyMcpl Moshi
 
Probiotic weaning food by monika keshavrao tambakhe
Probiotic weaning food by monika keshavrao tambakheProbiotic weaning food by monika keshavrao tambakhe
Probiotic weaning food by monika keshavrao tambakheMonika Tambakhe
 
Advancement in research for improving the ambient temperature stability of a ...
Advancement in research for improving the ambient temperature stability of a ...Advancement in research for improving the ambient temperature stability of a ...
Advancement in research for improving the ambient temperature stability of a ...Arup Nag
 
Kinetic principles in drug degradation
Kinetic principles in drug degradationKinetic principles in drug degradation
Kinetic principles in drug degradationTouheed Ovi
 
Furocyst an innovation is pcos management.. its publication &amp; presentati...
Furocyst  an innovation is pcos management.. its publication &amp; presentati...Furocyst  an innovation is pcos management.. its publication &amp; presentati...
Furocyst an innovation is pcos management.. its publication &amp; presentati...Chemical Resources (Chereso)
 
Essay About Module 1 Homework
Essay About Module 1 HomeworkEssay About Module 1 Homework
Essay About Module 1 HomeworkNatasha Johnson
 
Impact of non-processing technology in dairy products for microbial safety | ...
Impact of non-processing technology in dairy products for microbial safety | ...Impact of non-processing technology in dairy products for microbial safety | ...
Impact of non-processing technology in dairy products for microbial safety | ...FoodresearchLab
 
Parenteral preparation, equipments and layout
Parenteral preparation, equipments and layoutParenteral preparation, equipments and layout
Parenteral preparation, equipments and layoutswapnil_pharmacist
 
SMi Group's Lyophilization USA 2018
SMi Group's Lyophilization USA 2018SMi Group's Lyophilization USA 2018
SMi Group's Lyophilization USA 2018Dale Butler
 

Similar to Pediatric Antibiotic Innovations (20)

Biowaivers
BiowaiversBiowaivers
Biowaivers
 
Mkt 1043 stability and efficiency testing-SPPT23
Mkt 1043 stability and efficiency testing-SPPT23Mkt 1043 stability and efficiency testing-SPPT23
Mkt 1043 stability and efficiency testing-SPPT23
 
Bioavailability and Bioequivalence study
Bioavailability and Bioequivalence studyBioavailability and Bioequivalence study
Bioavailability and Bioequivalence study
 
Bioavailability and bioequivalence study
Bioavailability and bioequivalence studyBioavailability and bioequivalence study
Bioavailability and bioequivalence study
 
Probiotic weaning food by monika keshavrao tambakhe
Probiotic weaning food by monika keshavrao tambakheProbiotic weaning food by monika keshavrao tambakhe
Probiotic weaning food by monika keshavrao tambakhe
 
GMP design of parenteral production facility
GMP design of parenteral production facilityGMP design of parenteral production facility
GMP design of parenteral production facility
 
Advancement in research for improving the ambient temperature stability of a ...
Advancement in research for improving the ambient temperature stability of a ...Advancement in research for improving the ambient temperature stability of a ...
Advancement in research for improving the ambient temperature stability of a ...
 
FOY580 ppt.pdf
FOY580 ppt.pdfFOY580 ppt.pdf
FOY580 ppt.pdf
 
Kinetic principles in drug degradation
Kinetic principles in drug degradationKinetic principles in drug degradation
Kinetic principles in drug degradation
 
02_IJPBA_1938_21.pdf
02_IJPBA_1938_21.pdf02_IJPBA_1938_21.pdf
02_IJPBA_1938_21.pdf
 
Furocyst an innovation is pcos management.. its publication &amp; presentati...
Furocyst  an innovation is pcos management.. its publication &amp; presentati...Furocyst  an innovation is pcos management.. its publication &amp; presentati...
Furocyst an innovation is pcos management.. its publication &amp; presentati...
 
Essay About Module 1 Homework
Essay About Module 1 HomeworkEssay About Module 1 Homework
Essay About Module 1 Homework
 
Formas farmacéuticas
Formas farmacéuticasFormas farmacéuticas
Formas farmacéuticas
 
Impact of non-processing technology in dairy products for microbial safety | ...
Impact of non-processing technology in dairy products for microbial safety | ...Impact of non-processing technology in dairy products for microbial safety | ...
Impact of non-processing technology in dairy products for microbial safety | ...
 
Parenteral preparation, equipments and layout
Parenteral preparation, equipments and layoutParenteral preparation, equipments and layout
Parenteral preparation, equipments and layout
 
Research paper
Research paperResearch paper
Research paper
 
Stability Basic
Stability BasicStability Basic
Stability Basic
 
SMi Group's Lyophilization USA 2018
SMi Group's Lyophilization USA 2018SMi Group's Lyophilization USA 2018
SMi Group's Lyophilization USA 2018
 
02_IJPBA_1938_21.pdf
02_IJPBA_1938_21.pdf02_IJPBA_1938_21.pdf
02_IJPBA_1938_21.pdf
 
sup 505.pptx
sup 505.pptxsup 505.pptx
sup 505.pptx
 

More from Leith Greenslade

Breastmilk and the Infant Microbiome
Breastmilk and the Infant MicrobiomeBreastmilk and the Infant Microbiome
Breastmilk and the Infant MicrobiomeLeith Greenslade
 
Introduction to the "Bridge" - a new breastfeeding support tool
Introduction to the "Bridge" - a new breastfeeding support tool Introduction to the "Bridge" - a new breastfeeding support tool
Introduction to the "Bridge" - a new breastfeeding support tool Leith Greenslade
 
"The Own Mother's Milk (OMM) Economic Value Calculator": A New Tool to Save L...
"The Own Mother's Milk (OMM) Economic Value Calculator": A New Tool to Save L..."The Own Mother's Milk (OMM) Economic Value Calculator": A New Tool to Save L...
"The Own Mother's Milk (OMM) Economic Value Calculator": A New Tool to Save L...Leith Greenslade
 
“Own Mother's Milk (OMM) Economic Value Calculator": increasing access to hum...
“Own Mother's Milk (OMM) Economic Value Calculator": increasing access to hum...“Own Mother's Milk (OMM) Economic Value Calculator": increasing access to hum...
“Own Mother's Milk (OMM) Economic Value Calculator": increasing access to hum...Leith Greenslade
 
Launch of Resource Toolkit for Establishing and Integrating Human Milk Banks
Launch of Resource Toolkit for Establishing and Integrating Human Milk BanksLaunch of Resource Toolkit for Establishing and Integrating Human Milk Banks
Launch of Resource Toolkit for Establishing and Integrating Human Milk BanksLeith Greenslade
 
Challenges in Breastfeeding and Breastmilk Feeding in NICUs in India
Challenges in Breastfeeding and Breastmilk Feeding in NICUs in IndiaChallenges in Breastfeeding and Breastmilk Feeding in NICUs in India
Challenges in Breastfeeding and Breastmilk Feeding in NICUs in IndiaLeith Greenslade
 
Innovations in Breastfeeding and Breastmilk Feeding in the NICU
Innovations in Breastfeeding and Breastmilk Feeding in the NICUInnovations in Breastfeeding and Breastmilk Feeding in the NICU
Innovations in Breastfeeding and Breastmilk Feeding in the NICULeith Greenslade
 
"Food for Thought: an Independent Assessment of the International Code of Mar...
"Food for Thought: an Independent Assessment of the International Code of Mar..."Food for Thought: an Independent Assessment of the International Code of Mar...
"Food for Thought: an Independent Assessment of the International Code of Mar...Leith Greenslade
 
A New Tool for Collecting Colostrum: Jules Sherman
A New Tool for Collecting Colostrum: Jules ShermanA New Tool for Collecting Colostrum: Jules Sherman
A New Tool for Collecting Colostrum: Jules ShermanLeith Greenslade
 
Breastfeeding & AI: could an Alexa Answer Bot increase breastfeeding rates?
Breastfeeding & AI: could an Alexa Answer Bot increase breastfeeding rates?Breastfeeding & AI: could an Alexa Answer Bot increase breastfeeding rates?
Breastfeeding & AI: could an Alexa Answer Bot increase breastfeeding rates?Leith Greenslade
 
Why is it so hard to reduce household air pollution among the very poor?
Why is it so hard to reduce household air pollution among the very poor?Why is it so hard to reduce household air pollution among the very poor?
Why is it so hard to reduce household air pollution among the very poor?Leith Greenslade
 
Economics of Human Milk in Very Low Birth Weight Infants
Economics of Human Milk in Very Low Birth Weight InfantsEconomics of Human Milk in Very Low Birth Weight Infants
Economics of Human Milk in Very Low Birth Weight InfantsLeith Greenslade
 
Making NICUs Breastfeeding-Friendly: Meena Joshi
Making NICUs Breastfeeding-Friendly: Meena JoshiMaking NICUs Breastfeeding-Friendly: Meena Joshi
Making NICUs Breastfeeding-Friendly: Meena JoshiLeith Greenslade
 
Growing the Number of Quality Human Milk Banks: Kimberly Amundson
Growing the Number of Quality Human Milk Banks: Kimberly Amundson Growing the Number of Quality Human Milk Banks: Kimberly Amundson
Growing the Number of Quality Human Milk Banks: Kimberly Amundson Leith Greenslade
 
Breastfeeding Sick and Vulnerable Newborns, Why Invest in Research?: Mary Ren...
Breastfeeding Sick and Vulnerable Newborns, Why Invest in Research?: Mary Ren...Breastfeeding Sick and Vulnerable Newborns, Why Invest in Research?: Mary Ren...
Breastfeeding Sick and Vulnerable Newborns, Why Invest in Research?: Mary Ren...Leith Greenslade
 
New Training Guide to Help Babies with Special Needs to Breastfeed: MAITS
New Training Guide to Help Babies with Special Needs to Breastfeed: MAITSNew Training Guide to Help Babies with Special Needs to Breastfeed: MAITS
New Training Guide to Help Babies with Special Needs to Breastfeed: MAITSLeith Greenslade
 
The Health & Economic Value of Breastmilk for Preterm Babies: Medela
The Health & Economic Value of Breastmilk for Preterm Babies: MedelaThe Health & Economic Value of Breastmilk for Preterm Babies: Medela
The Health & Economic Value of Breastmilk for Preterm Babies: MedelaLeith Greenslade
 
Human Milk Bank Hazard Analysis Plan: Trainee Workbook
Human Milk Bank Hazard Analysis Plan: Trainee WorkbookHuman Milk Bank Hazard Analysis Plan: Trainee Workbook
Human Milk Bank Hazard Analysis Plan: Trainee WorkbookLeith Greenslade
 
Human Milk Bank Hazard Analysis Plan, Trainer's Guide
Human Milk Bank Hazard Analysis Plan, Trainer's GuideHuman Milk Bank Hazard Analysis Plan, Trainer's Guide
Human Milk Bank Hazard Analysis Plan, Trainer's GuideLeith Greenslade
 

More from Leith Greenslade (20)

Breastmilk and the Infant Microbiome
Breastmilk and the Infant MicrobiomeBreastmilk and the Infant Microbiome
Breastmilk and the Infant Microbiome
 
Introduction to the "Bridge" - a new breastfeeding support tool
Introduction to the "Bridge" - a new breastfeeding support tool Introduction to the "Bridge" - a new breastfeeding support tool
Introduction to the "Bridge" - a new breastfeeding support tool
 
"The Own Mother's Milk (OMM) Economic Value Calculator": A New Tool to Save L...
"The Own Mother's Milk (OMM) Economic Value Calculator": A New Tool to Save L..."The Own Mother's Milk (OMM) Economic Value Calculator": A New Tool to Save L...
"The Own Mother's Milk (OMM) Economic Value Calculator": A New Tool to Save L...
 
“Own Mother's Milk (OMM) Economic Value Calculator": increasing access to hum...
“Own Mother's Milk (OMM) Economic Value Calculator": increasing access to hum...“Own Mother's Milk (OMM) Economic Value Calculator": increasing access to hum...
“Own Mother's Milk (OMM) Economic Value Calculator": increasing access to hum...
 
Launch of Resource Toolkit for Establishing and Integrating Human Milk Banks
Launch of Resource Toolkit for Establishing and Integrating Human Milk BanksLaunch of Resource Toolkit for Establishing and Integrating Human Milk Banks
Launch of Resource Toolkit for Establishing and Integrating Human Milk Banks
 
Challenges in Breastfeeding and Breastmilk Feeding in NICUs in India
Challenges in Breastfeeding and Breastmilk Feeding in NICUs in IndiaChallenges in Breastfeeding and Breastmilk Feeding in NICUs in India
Challenges in Breastfeeding and Breastmilk Feeding in NICUs in India
 
Innovations in Breastfeeding and Breastmilk Feeding in the NICU
Innovations in Breastfeeding and Breastmilk Feeding in the NICUInnovations in Breastfeeding and Breastmilk Feeding in the NICU
Innovations in Breastfeeding and Breastmilk Feeding in the NICU
 
"Food for Thought: an Independent Assessment of the International Code of Mar...
"Food for Thought: an Independent Assessment of the International Code of Mar..."Food for Thought: an Independent Assessment of the International Code of Mar...
"Food for Thought: an Independent Assessment of the International Code of Mar...
 
A New Tool for Collecting Colostrum: Jules Sherman
A New Tool for Collecting Colostrum: Jules ShermanA New Tool for Collecting Colostrum: Jules Sherman
A New Tool for Collecting Colostrum: Jules Sherman
 
Breastfeeding & AI: could an Alexa Answer Bot increase breastfeeding rates?
Breastfeeding & AI: could an Alexa Answer Bot increase breastfeeding rates?Breastfeeding & AI: could an Alexa Answer Bot increase breastfeeding rates?
Breastfeeding & AI: could an Alexa Answer Bot increase breastfeeding rates?
 
Why is it so hard to reduce household air pollution among the very poor?
Why is it so hard to reduce household air pollution among the very poor?Why is it so hard to reduce household air pollution among the very poor?
Why is it so hard to reduce household air pollution among the very poor?
 
Economics of Human Milk in Very Low Birth Weight Infants
Economics of Human Milk in Very Low Birth Weight InfantsEconomics of Human Milk in Very Low Birth Weight Infants
Economics of Human Milk in Very Low Birth Weight Infants
 
Making NICUs Breastfeeding-Friendly: Meena Joshi
Making NICUs Breastfeeding-Friendly: Meena JoshiMaking NICUs Breastfeeding-Friendly: Meena Joshi
Making NICUs Breastfeeding-Friendly: Meena Joshi
 
Growing the Number of Quality Human Milk Banks: Kimberly Amundson
Growing the Number of Quality Human Milk Banks: Kimberly Amundson Growing the Number of Quality Human Milk Banks: Kimberly Amundson
Growing the Number of Quality Human Milk Banks: Kimberly Amundson
 
Breastfeeding Sick and Vulnerable Newborns, Why Invest in Research?: Mary Ren...
Breastfeeding Sick and Vulnerable Newborns, Why Invest in Research?: Mary Ren...Breastfeeding Sick and Vulnerable Newborns, Why Invest in Research?: Mary Ren...
Breastfeeding Sick and Vulnerable Newborns, Why Invest in Research?: Mary Ren...
 
New Training Guide to Help Babies with Special Needs to Breastfeed: MAITS
New Training Guide to Help Babies with Special Needs to Breastfeed: MAITSNew Training Guide to Help Babies with Special Needs to Breastfeed: MAITS
New Training Guide to Help Babies with Special Needs to Breastfeed: MAITS
 
The Health & Economic Value of Breastmilk for Preterm Babies: Medela
The Health & Economic Value of Breastmilk for Preterm Babies: MedelaThe Health & Economic Value of Breastmilk for Preterm Babies: Medela
The Health & Economic Value of Breastmilk for Preterm Babies: Medela
 
United for Oxygen
United for OxygenUnited for Oxygen
United for Oxygen
 
Human Milk Bank Hazard Analysis Plan: Trainee Workbook
Human Milk Bank Hazard Analysis Plan: Trainee WorkbookHuman Milk Bank Hazard Analysis Plan: Trainee Workbook
Human Milk Bank Hazard Analysis Plan: Trainee Workbook
 
Human Milk Bank Hazard Analysis Plan, Trainer's Guide
Human Milk Bank Hazard Analysis Plan, Trainer's GuideHuman Milk Bank Hazard Analysis Plan, Trainer's Guide
Human Milk Bank Hazard Analysis Plan, Trainer's Guide
 

Recently uploaded

Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdfHongBiThi1
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfDolisha Warbi
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfMedicoseAcademics
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaSujoy Dasgupta
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 

Recently uploaded (20)

Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
How to master Steroid (glucocorticoids) prescription, different scenarios, ca...
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdfSGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA    .pdf
SGK NGẠT NƯỚC ĐHYHN RẤT LÀ HAY NHA .pdf
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdfPAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
PAIN/CLASSIFICATION AND MANAGEMENT OF PAIN.pdf
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
Red Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdfRed Blood Cells_anemia & polycythemia.pdf
Red Blood Cells_anemia & polycythemia.pdf
 
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy DasguptaMale Infertility Panel Discussion by Dr Sujoy Dasgupta
Male Infertility Panel Discussion by Dr Sujoy Dasgupta
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 

Pediatric Antibiotic Innovations

  • 1. Sangwei Lu, Ph.D. School of Public Health University of California Berkeley, California U. S. A. Email: sangwei@berkeley.edu Phone: (510) 643-4986 Website: http://sph.berkeley.edu/sangwei-lu Novel, Peanut Butter – Based Formulation of Amoxicillin - Toward a child–friendly formulation of amoxicillin that is stable, ready to use and nutritious
  • 2. The Need for a Child –Friendly Formulation of Amoxicillin • Young children cannot swallow pills. • Needs clean water to reconstitute • Needs refrigeration once reconstituted • Heavy to transport once reconstituted Peanut butter – based formulation of amoxicillin (NutMox) • Child-friendly and nutritious • Ready to use and light weight; no refrigeration necessary • Can be combined with RUTF therapy based on updated WHO guidelines of management of severe acute malnutrition in children Sangwei Lu, PhD, sangwei@berkeley.edu Novel, Peanut Butter – Based Formulation of Amoxicillin
  • 3. Design of Peanut Butter–Based Formulation of Amoxicillin packaged and distributed as a single course of antibiotic treatment Advantages • Easy to handle • Easy to track • Helps ensure completion of full course of treatment and prevent emergence of drug resistance Sangwei Lu, PhD, sangwei@berkeley.edu Novel, Peanut Butter – Based Formulation of Amoxicillin
  • 4. Project Plan • Formulate a suitable peanut butter base for amoxicillin • Test the long term stability of amoxicillin in the peanut butter base under various storage temperatures • Determine the pharmacokinetics of NutMox in an animal model • Test the efficacy of NutMox in a mouse pneumonia model. Preliminary Results • Amoxicillin is very stable in peanut butter base with various ratios of peanut butter, sugar, vegetable oil and dry milk. • Peanut butter base does not prevent amoxicillin from being released into mouse bloodstream. Sangwei Lu, PhD, sangwei@berkeley.edu Novel, Peanut Butter – Based Formulation of Amoxicillin
  • 5. • Prepare in vitro data for FDA Investigational New Drug (IND) filing. • Clinical trial – bioequivalence study • FDA New Drug Application (NDA) filing • Partner with pharmaceutical companies, NGOs and non-profit organizations. Future Directions - Path to Clinical Use Community Input • Requirements and feasibility of NutMox in the field • Regulatory requirements of the countries NutMox is most likely to be used • Route of distribution • Connection with clinicians and organizations Sangwei Lu, PhD, sangwei@berkeley.edu Novel, Peanut Butter – Based Formulation of Amoxicillin
  • 6. UCL SCHOOL OF PHARMACY BRUNSWICK SQUARE Child Friendly Formulations of Amoxicillin: RAMOX Dr Catherine Tuleu, Reader of Pharmaceutics Dr Sara Hanning, Research Associate UCL School of Pharmacy, London, UK
  • 7. UCL SCHOOL OF PHARMACY BRUNSWICK SQUARE Paediatric Pharmacy R & D  Manipulation & Compounding – Reformulation/repurposing of API for (ultra) rare diseases – Palliative care  Excipients tolerability and safety – STEP Database (www.eupfi.org)  Appropriateness of dosage forms (including acceptability) – RAMOX – Multiparticulates – Flexible solid oral dosage forms  Palatability of formulations – In vivo (human panels)/in vitro (BATA model) tools – HME for TM of FDC TB drugs – Cocrystals for TM for neglected infectious diseases  Drug delivery/administration devices – Nipple shield 7
  • 8. UCL SCHOOL OF PHARMACY BRUNSWICK SQUARE Child-friendly formulations of amoxicillin: Exploring the rectal route Jannin V, Lemagnen G, Gueroult P, Larrouture D, Tuleu C (2014). Advanced Drug Delivery Reviews 73(0):34-49. 8
  • 9. UCL SCHOOL OF PHARMACY BRUNSWICK SQUARE Advantages  Low manufacture cost  Ease of administration (no need for trained carers)  Avoidance of taste/swallowability concerns Challenges  Ability to withstand high- temperature environments  Offer immediate and predictable drug release in vivo The rectal route
  • 10. UCL SCHOOL OF PHARMACY BRUNSWICK SQUARE  Screen potential excipients for irritability  Development, optimisation and characterisation of formulations  Physical and chemical data essential to ensure quality, stability and an immediate drug release profile  PPI …to bring forward to Phase II  Clinical efficacy  Paediatric Investigation Plan (PIP)/Paediatric Use Marketing Authorisation (PUMA)  Educational material to promote and support rectal administration Phase I: Pharmaceutical development 10 Phase II: Translation of research
  • 11. The Challenge Beta-lactam bonds in amoxicillin are hydrolyzed (broken down) by water causing reconstituted amoxicillin the degenerate within 2 weeks and faster if no cold chain (refrigeration) is present. DOM (dissolved organic matter) also contribute to 48-74% of amoxicillin loss if reconstituted with natural waters. Direct sunlight further contributes to the photochemical degradation especially in the presence of DOM. Problems encountered in low resource settings No refrigeration “Dirty” water – leading to contamination of the reconstituted antibiotic – also contains DOM High temperatures in some parts of the developing world – Africa, South East Asia etc Hypothesis If water hydrolyzes the Beta-lactam bonds it is acceptable to say oil will not. An oil based suspension will lead to a suspension that will stay chemically stable with therapeutic efficacy intact for periods of up to 2 years, without cold chain and at very high temperatures as experienced in many parts of the world.
  • 12. Water: is a polar molecule with a dipole moment can act as an acid or a base (Bronsted Lowry) has strong hydrogen bonds Amoxicillin: is predominantly a polar molecule (polar dissolves in polar) Oil : is a non-polar molecule Other issues with water in LMICs: Water is mostly contaminated and contains dissolved organic matter DOMs accelerate hydrolysis PH also plays a role – should be between 3 and 6 (approximate) Temperature – in water should be at between 4 and 8 Celsius At temperatures above 37 Celsius – hydrolysis is accelerated Direct sunight – accelerates photolysis Benefits of an oil based suspension: • Such a suspension will not require refrigeration, • will eliminate contamination risks • stay stable at very high temperatures of 40 to 50 degrees Celsius. • Added benefit of using oil is that oil provides plus minus 9 calories per gram, giving more energy to the child to fight the infection. • Individualized dosing units clearly marked for populations of LMICs
  • 13. • Mix amoxicillin with various non-volatile oils and triglycerides. • Add silicon dioxide as adsorbent and anti-caking agent • Any flavoring and colorant can be added Testing conditions as per generic protocol (WHO) and USP • Long term testing conditions for South Africa (Zone II) = 25°C/60%RH • Long Term Testing conditions for Zone IVB countries (hot and very humid conditions) + intermediate conditions for Zone II = 30°C/75%RH • Accelerated stability testing conditions = 40°C/75%RH • *%RH = Relative Humidity .
  • 14. Stability Testing Phase I Method and Metrics Desired Outcome Physical analysis: Description and Appearance; odour, colour, palatability, uniformity, dissolution Original physical properties are retained Chemical analysis: Ph, density, viscosity Original chemical properties are retained Re-suspendability Suspendability is retained Uniformity of dosing units: weight variation Chemical integrity and labelled potency are retained Chemical assay: Assay Amox Suitability of method must be proven Sterility No contamination Microbiological: resistance to microbiological growth and no contamination Amoxicillin retains its antimicrobial effectiveness Photostability: direct sunlight Determine suitability of amber/clear ampoules
  • 15. Research Phase II Method and Metrics Desired Outcome Therapeutic efficacy Remains unchanged Bioavailability Remains within specified limits Safety Safety remains within current limits Toxicological No increase in adverse events and side effects Our product will be safe with no added allergens and we expect no increase in side effects and adverse events. Conclusion Amoxicillin is an existing API - all testing should remain within current limitations. However, if we could include a comparative study our data will be more unbiased and we will be able to accelerate phase I and II drastically – especially if we could test both child formulations 125mg/5ml and 250mg/5ml. THANK YOU
  • 16. A Thixotropic System for Oral Delivery of Amoxicillin in Treating Pneumonia in Children Chenjie Xu Assistant Professor School of Chemical and Biomedical Engineering Nanyang Technological University Singapore 16
  • 17. Challenges of Amoxicillin Delivery to Children (0-5 yrs) at High Burden Countries http://www.envita.com/ Amoxicillin 17
  • 18. Criteria of an Ideal Formulation 1. Taste-masked 2. Easy to swallow 3. No need of clean water 4. Improved shelf life without the need of refrigeration 5. Low cost http://gcgh.grandchallenges.org/Explorations/Topics/Pages/ChildhoodPneumoniaTreatment_Round14.aspx 18
  • 19. Birth of Idea Images are adapted from Waker silicone electronic business. Co. Ltd 19
  • 20. Components of a Thixotropic System 1. A coating that blocks the unappealing taste and odor of Amoxicillin; 2. A water-containing matrix that disperses, stabilizes, and delivers the drug. 20
  • 21. Spray-drying Synthesis of Amoxicillin Micro/nano-particles • Poly(meth)acrylates polymer (trade name: EUDRAGIT® E) seals taste and masks odor. • Soluble in solution (pH <5.0) Amoxicillin • Poorly water-soluble (0.004g/ml) • Insoluble in organic solvents like chloroform. • Its sodium salt is soluble in water (0.05g/ml) An acidic solution of Amoxicillin sodium and Eugragit E Harsha S. Drug design, development and therapy 2013, 7, 1027 Khachane,P et al, Journal of biomedical nanotechnology 2001, 7, 590 21
  • 22. Encapsulation of Amoxicillin Particles in Sodium Carboxymethyl Cellulose Hydrogel High and medium-viscosity types of sodium carboxymethyl cellulose (SCC) solution exhibit thixotropic behavior and acts like liquid under the pressure. http://www.dow.com/; Lee, C.H., Moturi, V. & Lee, Y. Journal of Controlled Release 2009, 136, 88 + SCCAmoxicillin Particles Mechanical Stirring 22

Editor's Notes

  1. Intro – rectal amoxicillin Outline – background into research group, outline of our project, plan of attack
  2. Former CPPR (center for paediatric pharmacy research since 2002) – long established relationship with ICH and GOSH Formulation but also research capacity on PK PD PG + drug use and safety Formulation team = 4 post doc 1RA 5 PhD 2 Msc 2 visiting students (undergrad Mpahrm research students) Formulations for developing countries
  3. State aim: To address the paucity of age appropriate amoxicillin formulations by developing an innovative, child-friendly rectal dosage form of amoxicillin Pneumonia is the leading cause of mortality in children < 5 First-line treatment: amoxicillin 250mg Child-friendly dosage forms unavailable in many countries Manipulation of adult dosage forms Compromised efficacy, adherence, medicine stability
  4. Phase 1 -Screen potential excipients for irritability using slug assay -Development, optimisation and characterisation of formulations -Generation of essential physical and chemical data to ensure quality, stability and an immediate drug release profile to bring forward to Phase II
  5. Amoxicillin is an antibiotic useful for the treatment of a number of bacterial infections. it is better-absorbed, following oral administration, than other β-lactam antibiotics. Amoxicillin is one of the most common antibiotics prescribed for children.
  6. Amoxicillin particles will be embedded in a gel-like sodium carboxymethyl cellulose solution to protect and stabilize the formulation for long-term storage. Challenges: Recommended child oral dosage of amoxicillin for pneumococcus is ~50 mg/kg every 12 hours. For a 10-20kg child, 0.5-1g amoxicillin is to be delivered. As a child can usually swallow <5 ml solution at a time, the concentration of amoxicillin in the hydrogel would be ideally above 0.1g/ml.